Who Owns Biodexa Pharmaceuticals American Depositary Shs Stock?
NASDAQ: BDRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 0.40%
- Held by insiders
- 0.00%
- Institutional holders
- 8
- Institutions 0.4%
- Insiders 0.0%
- Public and other 99.6%
Who owns Biodexa Pharmaceuticals American Depositary Shs stock?
Institutional investors own about 0.4% of Biodexa Pharmaceuticals American Depositary Shs's shares, spread across 8 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 0.00% of BDRX.
The largest institutional holders are Armistice Capital, LLC (0.35%), Gamma Investing LLC (0.03%) and Allied Private Wealth LLC (0.01%). Together, the top 7 institutions control 0.4% of shares outstanding. In their latest filings, 2 of the top 7 institutions increased their BDRX positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of BDRX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Armistice Capital, LLC | 14.81K | 0.35% | -24.1% |
| Gamma Investing LLC | 1.20K | 0.03% | -56.4% |
| Allied Private Wealth LLC | 489 | 0.01% | +100.0% |
| SBI Securities Co., Ltd. | 29 | 0.00% | -80.8% |
| UBS Group AG | 25 | 0.00% | 0.0% |
| Hilton Head Capital Partners, LLC | 6 | 0.00% | 0.0% |
| Caitong International Asset Management Co., Ltd | 5 | 0.00% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of BDRX
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 78 | 0.00% |
Frequently asked questions
Who is the largest shareholder of Biodexa Pharmaceuticals American Depositary Shs?
Armistice Capital, LLC is the largest institutional shareholder of BDRX, owning 0.35% of shares outstanding (14.81K shares) as of its latest 13F filing.
What percentage of Biodexa Pharmaceuticals American Depositary Shs is owned by institutions?
Institutions own about 0.4% of BDRX shares and 0.4% of the public float.
How much of Biodexa Pharmaceuticals American Depositary Shs do insiders own?
Insiders, such as officers and directors, own about 0.00% of BDRX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.